Imatinib mesylate | |
【CAS】 220127-57-1 |
|
【Synonyms】 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate 4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate CGP-57148B GLEEVEC GLIVEC IMATINIB MESYLATE IMATINIB METHANESULFONATE STI-571 IMATINIB BASE(IMA-3) ImatinibMesylate/Gleevec Imatinib Methanesulfonate, STI-571, CGP-57148B, Glivec, IMATINIB MESYLATE (IMATINIB METHANESULFONATE) alpha-IMATINIB MESYLATE Imatinib mesylate(TINIBS ) 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate Imatinib mesylate Imatinib mesylate / 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate |
|
【Molecular Formula】 【Molecular Structure】
|
|
【MDL Number】 MFCD04307699 |
|
【Molecular Weight】 589.71 |
|
【MOL File】 220127-57-1.mol |
Chemical Properties | Back Directory |
【Appearance】 Off-White Solid |
|
【Usage】 A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL) |